Atlas Trials

AlloVir

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch AlloVir

RecordFirmDate
Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation (NCT05179057)AlloVir2022-04-26
Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (NCT05305040)AlloVir2022-03-24
Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant (NCT04933968)AlloVir2022-03-21
Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) (NCT04390113)AlloVir2021-03-18
Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (NCT04693637)AlloVir2021-01-15
Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B) (NCT02313844)AlloVir2018-03-01
Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A) (NCT02276820)AlloVir2017-12-07

Track AlloVir automatically

Every clearance here is in the API, with alerts when new ones post.